Transforming growth factor β receptor type 1 is essential for female reproductive tract integrity and function

PLoS Genetics

Volumn 7, Issue 10, 2011, Pages

  Li, Qinglei ^a,b   Agno, Julio E ^a   Edson, Mark A ^a   Nagaraja, Ankur K ^a   Nagashima, Takashi ^a   Matzuk, Martin M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; DICER; GROWTH DIFFERENTIATION FACTOR 9; MUELLERIAN INHIBITING FACTOR; RECEPTOR ANTIBODY; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; ANTI MULLERIAN HORMONE RECEPTOR; ANTI-MULLERIAN HORMONE RECEPTOR; GDF9 PROTEIN, MOUSE; INTEGRASE; PROGESTERONE; PROTEIN SERINE THREONINE KINASE; RECEPTOR; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ACE2 GENE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; FEMALE FERTILITY; FEMALE GENITAL SYSTEM FUNCTION; FEMALE STERILITY; GENE; GENE EXPRESSION; GENE LOCATION; GENE TRANSFER; GENETIC ASSOCIATION; IN VITRO STUDY; IN VIVO STUDY; KRT12 GENE; MOUSE; MUSCLE DEVELOPMENT; MYOR GENE; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; UTERUS DISEASE; ANIMAL; BLOOD; C57BL MOUSE; CELL CULTURE; CELL STRAIN HEK293; CONGENITAL MALFORMATION; DIVERTICULOSIS; FERTILITY; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; MOUSE MUTANT; PATHOLOGY; PRENATAL DEVELOPMENT; REPRODUCTION; UTERINE TUBE; UTERUS;

MUS;

ANIMALS; CELLS, CULTURED; DIVERTICULUM; EMBRYONIC DEVELOPMENT; FALLOPIAN TUBES; FEMALE; FERTILITY; GROWTH DIFFERENTIATION FACTOR 9; HEK293 CELLS; HUMANS; INTEGRASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH; PROGESTERONE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, PEPTIDE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REPRODUCTIVE PHYSIOLOGICAL PROCESSES; UTERUS;

EID: 80055076622     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1002320     Document Type: Article

References (102)

1. Massague J, Blain SW, Lo RS, (2000) TGFβ signaling in growth control, cancer, and heritable disorders. Cell 103: 295-309.
2. Chang H, Brown CW, Matzuk MM, (2002) Genetic analysis of the mammalian transforming growth factor-β superfamily. Endocr Rev 23: 787-823.
3. Juengel JL, McNatty KP, (2005) The role of proteins of the transforming growth factor-beta superfamily in the intraovarian regulation of follicular development. Hum Reprod Update 11: 144-161.
4. Padua D, Massague J, (2009) Roles of TGFbeta in metastasis. Cell Res 19: 89-102.
5. Bellam N, Pasche B, (2010) TGF-beta signaling alterations and colon cancer. Cancer Treat Res 155: 85-103.
6. Ikushima H, Miyazono K, (2010) TGF-beta signalling: a complex web in cancer progression. Nat Rev Cancer 10: 415-424.
7. Massague J, (2000) How cells read TGF-beta signals. Nat Rev Mol Cell Biol 1: 169-178.
8. Attisano L, Wrana JL, (2002) Signal transduction by the TGF-beta superfamily. Science 296: 1646-1647.
9. Derynck R, Zhang YE, (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577-584.
10. Massague J, (1992) Receptors for the TGF-beta family. Cell 69: 1067-1070.
11. Massague J, (1998) TGF-beta signal transduction. Annu Rev Biochem 67: 753-791.
12. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, et al. (1996) Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 383: 531-535.
13. Hayashi M, McGee EA, Min G, Klein C, Rose UM, et al. (1999) Recombinant growth differentiation factor-9 (GDF-9) enhances growth and differentiation of cultured early ovarian follicles. Endocrinology 140: 1236-1244.
14. Myers M, Pangas SA, (2010) Regulatory roles of transforming growth factor beta family members in folliculogenesis. Wiley Interdiscip Rev Syst Biol Med 2: 117-125.
15. Nagaraja AK, Middlebrook BS, Rajanahally S, Myers M, Li Q, et al. (2010) Defective gonadotropin-dependent ovarian folliculogenesis and granulosa cell gene expression in inhibin-deficient mice. Endocrinology 151: 4994-5006.
16. Dragovic RA, Ritter LJ, Schulz SJ, Amato F, Thompson JG, et al. (2007) Oocyte-secreted factor activation of SMAD 2/3 signaling enables initiation of mouse cumulus cell expansion. Biol Reprod 76: 848-857.
17. Diaz FJ, Wigglesworth K, Eppig JJ, (2007) Oocytes determine cumulus cell lineage in mouse ovarian follicles. J Cell Sci 120: 1330-1340.
18. Li Q, Pangas SA, Jorgez CJ, Graff JM, Weinstein M, et al. (2008) Redundant roles of SMAD2 and SMAD3 in ovarian granulosa cells in vivo. Mol Cell Biol 28: 7001-7011.
19. Lee KY, Jeong JW, Wang J, Ma L, Martin JF, et al. (2007) Bmp2 is critical for the murine uterine decidual response. Mol Cell Biol 27: 5468-5478.
20. Roelen BA, Lin HY, Knezevic V, Freund E, Mummery CL, (1994) Expression of TGF-βs and their receptors during implantation and organogenesis of the mouse embryo. Dev Biol 166: 716-728.
21. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A, (1992) Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360: 313-319.
22. Li Q, Graff JM, O'Connor AE, Loveland KL, Matzuk MM, (2007) SMAD3 regulates gonadal tumorigenesis. Mol Endocrinol 21: 2472-2486.
23. Pangas SA, Li X, Umans L, Zwijsen A, Huylebroeck D, et al. (2008) Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice. Mol Cell Biol 28: 248-257.
24. Massague J, (2008) TGFbeta in Cancer. Cell 134: 215-230.
25. Middlebrook BS, Eldin K, Li X, Shivasankaran S, Pangas SA, (2009) Smad1-Smad5 ovarian conditional knockout mice develop a disease profile similar to the juvenile form of human granulosa cell tumors. Endocrinology 150: 5208-5217.
26. Edson MA, Nalam RL, Clementi C, Franco HL, Demayo FJ, et al. (2010) Granulosa cell-expressed BMPR1A and BMPR1B have unique functions in regulating fertility but act redundantly to suppress ovarian tumor development. Mol Endocrinol 24: 1251-1266.
27. Chang H, Lau AL, Matzuk MM, (2001) Studying TGF-beta superfamily signaling by knockouts and knockins. Mol Cell Endocrinol 180: 39-46.
28. Pangas SA, Matzuk MM, (2008) The TGFβ family in the reproductive tract. In: Derynck R, Miyazono K, editors. TGFβ family New York Cold Spring Harbor Laboratory Press pp. 861-888.
29. Edson MA, Nagaraja AK, Matzuk MM, (2009) The mammalian ovary from genesis to revelation. Endocr Rev 30: 624-712.
30. Richards JS, Pangas SA, (2010) The ovary: basic biology and clinical implications. J Clin Invest 120: 963-972.
31. Matzuk MM, Kumar TR, Bradley A, (1995) Different phenotypes for mice deficient in either activins or activin receptor type II. Nature 374: 356-360.
32. Song J, Oh SP, Schrewe H, Nomura M, Lei H, et al. (1999) The type II activin receptors are essential for egg cylinder growth, gastrulation, and rostral head development in mice. Dev Biol 213: 157-169.
33. Lee SJ, Reed LA, Davies MV, Girgenrath S, Goad ME, et al. (2005) Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc Natl Acad Sci USA 102: 18117-18122.
34. Orvis GD, Jamin SP, Kwan KM, Mishina Y, Kaartinen VM, et al. (2008) Functional redundancy of TGF-beta family type I receptors and receptor-Smads in mediating anti-Mullerian hormone-induced Mullerian duct regression in the mouse. Biol Reprod 78: 994-1001.
35. Mazerbourg S, Klein C, Roh J, Kaivo-Oja N, Mottershead DG, et al. (2004) Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5. Mol Endocrinol 18: 653-665.
36. Elvin JA, Clark AT, Wang P, Wolfman NM, Matzuk MM, (1999) Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol Endocrinol 13: 1035-1048.
37. Matzuk MM, Burns KH, Viveiros MM, Eppig JJ, (2002) Intercellular communication in the mammalian ovary: oocytes carry the conversation. Science 296: 2178-2180.
38. Su YQ, Wu X, O'Brien MJ, Pendola FL, Denegre JN, et al. (2004) Synergistic roles of BMP15 and GDF9 in the development and function of the oocyte-cumulus cell complex in mice: genetic evidence for an oocyte-granulosa cell regulatory loop. Dev Biol 276: 64-73.
39. Gui L-M, Joyce IM, (2005) RNA interference evidence that growth differentiation factor-9 mediates oocyte regulation of cumulus expansion in mice. Biol Reprod 72: 195-199.
40. Su YQ, Sugiura k, Wigglesworth k, O'Brien MJ, Affourtit JP, et al. (2008) Oocyte regulation of metabolic cooperativity between mouse cumulus cells and oocytes: BMP15 and GDF9 control cholesterol biosynthesis in cumulus cells. Development 135: 111-121.
41. Myllymaa S, Pasternack A, Mottershead DG, Poutanen M, Pulkki MM, et al. (2010) Inhibition of oocyte growth factors in vivo modulates ovarian folliculogenesis in neonatal and immature mice. Reproduction 139: 587-598.
42. Li Q, McKenzie LJ, Matzuk MM, (2008) Revisiting oocyte-somatic cell interactions: in search of novel intrafollicular predictors and regulators of oocyte developmental competence. Mol Hum Reprod 14: 673-678.
43. Gilchrist RB, (2011) Recent insights into oocyte-follicle cell interactions provide opportunities for the development of new approaches to in vitro maturation. Reprod Fertil Dev 23: 23-31.
44. Larsson J, Goumans M-J, Sjostrand LJ, van Rooijen MA, Ward D, et al. (2001) Abnormal angiogenesis but intact hematopoietic potential in TGF-β type I receptor-deficient mice. EMBO J 20: 1663-1673.
45. Kos CH, (2004) Cre/loxP system for generating tissue-specific knockout mouse models. Nutr Rev 62: 243-246.
46. Pangas SA, Li X, Robertson EJ, Matzuk MM, (2006) Premature luteinization and cumulus cell defects in ovarian-specific Smad4 knockout mice. Mol Endocrinol 20: 1406-1422.
47. Pangas SA, Jorgez CJ, Tran M, Agno J, Li X, et al. (2007) Intraovarian activins are required for female fertility. Mol Endocrinol 21: 2458-2471.
48. Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR, (2002) Requirement of Bmpr1a for Mullerian duct regression during male sexual development. Nat Genet 32: 408-410.
49. Jorgez CJ, Klysik M, Jamin SP, Behringer RR, Matzuk MM, (2004) Granulosa cell-specific inactivation of follistatin causes female fertility defects. Mol Endocrinol 18: 953-967.
50. Petit FG, Jamin SP, Kurihara I, Behringer RR, DeMayo FJ, et al. (2007) Deletion of the orphan nuclear receptor COUP-TFII in uterus leads to placental deficiency. Proc Natl Acad Sci USA 104: 6293-6298.
51. Hong X, Luense LJ, McGinnis LK, Nothnick WB, Christenson LK, (2008) Dicer1 is essential for female fertility and normal development of the female reproductive system. Endocrinology 149: 6207-6212.
52. Gabriel G, Richard RB, (2009) Dicer is required for female reproductive tract development and fertility in the mouse. Mol Reprod Dev 76: 678-688.
53. Miller DJ, (2011) Physiology and endocrinology symposium: sperm-oviduct interactions in livestock and poultry. J Anim Sci 89: 1312-1314.
54. Wang Z, Wang D-Z, Pipes GCT, Olson EN, (2003) Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci USA 100: 7129-7134.
55. Nagaraja AK, Andreu-Vieyra C, Franco HL, Ma L, Chen R, et al. (2008) Deletion of Dicer in somatic cells of the female reproductive tract causes sterility. Mol Endocrinol 22: 2336-2352.
56. Davis BN, Hilyard AC, Lagna G, Hata A, (2008) SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454: 56-61.
57. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, et al. (2009) miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460: 705-710.
58. Xin M, Small EM, Sutherland LB, Qi X, McAnally J, et al. (2009) MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev 23: 2166-2178.
59. Cheng Y, Liu X, Yang J, Lin Y, Xu D-Z, et al. (2009) MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 105: 158-166.
60. Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, et al. (2009) The knockout of miR-143 and-145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 16: 1590-1598.
61. Nishida K, Honma Y, Dota A, Kawasaki S, Adachi W, et al. (1997) Isolation and chromosomal localization of a cornea-specific human keratin 12 gene and detection of four mutations in Meesmann corneal epithelial dystrophy. Am J Hum Genet 61: 1268-1275.
62. Karantza V, (2011) Keratins in health and cancer: more than mere epithelial cell markers. Oncogene 30: 127-138.
63. Owens GK, (1995) Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75: 487-517.
64. King KE, Iyemere VP, Weissberg PL, Shanahan CM, (2003) Kruppel-like factor 4 (KLF4/GKLF) is a target of bone morphogenetic proteins and transforming growth factor β1 in the regulation of vascular smooth muscle cell phenotype. J Biol Chem 278: 11661-11669.
65. Kennard S, Liu H, Lilly B, (2008) Transforming growth factor-β (TGF-β1) down-regulates Notch3 in fibroblasts to promote smooth muscle gene expression. J Biol Chem 283: 1324-1333.
66. Lovren F, Pan Y, Quan A, Teoh H, Wang G, et al. (2008) Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. Am J Physiol Heart Circ Physiol 295: H1377-1384.
67. Pangas SA, Matzuk MM, (2005) The art and artifact of GDF9 activity: cumulus expansion and the cumulus expansion-enabling factor. Biol Reprod 73: 582-585.
68. Yan C, Wang P, DeMayo J, DeMayo FJ, Elvin JA, et al. (2001) Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol 15: 854-866.
69. McNatty KP, Juengel JL, Wilson T, Galloway SM, Davis GH, (2001) Genetic mutations influencing ovulation rate in sheep. Reprod Fertil Dev 13: 549-555.
70. Shimasaki S, Moore RK, Otsuka F, Erickson GF, (2004) The bone morphogenetic protein system in mammalian reproduction. Endocr Rev 25: 72-101.
71. Yu PB, Hong CC, Sachidanandan C, Babitt JL, Deng DY, et al. (2008) Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 4: 33-41.
72. DaCosta Byfield S, Major C, Laping NJ, Roberts AB, (2004) SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. Mol Pharmacol 65: 744-752.
73. Moore RK, Otsuka F, Shimasaki S, (2003) Molecular basis of bone morphogenetic protein-15 signaling in granulosa cells. J Biol Chem 278: 304-310.
74. Gilchrist RB, Lane M, Thompson JG, (2008) Oocyte-secreted factors: regulators of cumulus cell function and oocyte quality. Hum Reprod Update 14: 159-177.
75. Arango NA, Kobayashi A, Wang Y, Jamin SP, Lee HH, et al. (2008) A mesenchymal perspective of Mullerian duct differentiation and regression in Amhr2-lacZ mice. Mol Reprod Dev 75: 1154-1162.
76. Aguilar HN, Mitchell BF, (2010) Physiological pathways and molecular mechanisms regulating uterine contractility. Hum Reprod Update 16: 725-744.
77. Tong D, Lu X, Wang HX, Plante I, Lui E, et al. (2009) A dominant loss-of-function GJA1 (Cx43) mutant impairs parturition in the mouse. Biol Reprod 80: 1099-1106.
78. Renthal NE, Chen CC, Williams KC, Gerard RD, Prange-Kiel J, et al. (2010) miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc Natl Acad Sci USA 107: 20828-20833.
79. Miller C, Sassoon DA, (1998) Wnt-7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract. Development 125: 3201-3211.
80. Wang Y, Jia Y, Franken P, Smits R, Ewing PC, et al. (2011) Loss of APC function in mesenchymal cells surrounding the Mullerian duct leads to myometrial defects in adult mice. Mol Cell Endocrinol 341: 48-54.
81. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
82. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A, (2010) Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell 39: 373-384.
83. Davis-Dusenbery BN, Hata A, (2011) Smad-mediated miRNA processing: A critical role for a conserved RNA sequence. RNA Biol 8: 71-76.
84. Boettger T, Beetz N, Kostin S, Schneider J, Kruger M, et al. (2009) Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest 119: 2634-2647.
85. DiSandro MJ, Li Y, Baskin LS, Hayward S, Cunha G, (1998) Mesenchymal-epithelial interactions in bladder smooth muscle development: epithelial specificity. J Urol 160: 1040-1046.
86. Yu L, Mikloucich J, Sangster N, Perez A, McCormick PJ, (2003) MyoR is expressed in nonmyogenic cells and can inhibit their differentiation. Exp Cell Res 289: 162-173.
87. Lu J, Webb R, Richardson JA, Olson EN, (1999) MyoR: a muscle-restricted basic helix-loop-helix transcription factor that antagonizes the actions of MyoD. Proc Natl Acad Sci USA 96: 552-557.
88. Zhang F, Hu Y, Xu Q, Ye S, (2010) Different effects of angiotensin II and angiotensin-(1-7) on vascular smooth muscle cell proliferation and migration. PLoS ONE 5: e12323 doi:10.1371/journal.pone.0012323.
89. Yaghini FA, Song CY, Lavrentyev EN, Ghafoor HU, Fang XR, et al. (2010) Angiotensin II-induced vascular smooth muscle cell migration and growth are mediated by cytochrome P450 1B1-dependent superoxide generation. Hypertension 55: 1461-1467.
90. Roy H, Bhardwaj S, Yla-Herttuala S, (2006) Biology of vascular endothelial growth factors. FEBS Lett 580: 2879-2887.
91. Banerjee S, Mehta S, Haque I, Sengupta K, Dhar K, et al. (2008) VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis. Biochemistry 47: 3345-3351.
92. Ishida A, Murray J, Saito Y, Kanthou C, Benzakour O, et al. (2001) Expression of vascular endothelial growth factor receptors in smooth muscle cells. J Cell Physiol 188: 359-368.
93. Jeon SH, Chae BC, Kim HA, Seo GY, Seo DW, et al. (2007) Mechanisms underlying TGF-beta1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis. J Leukoc Biol 81: 557-566.
94. Schmierer B, Hill CS, (2007) TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 8: 970-982.
95. Li Q, Rajanahally S, Edson MA, Matzuk MM, (2009) Stable expression and characterization of N-terminal tagged recombinant human bone morphogenetic protein 15. Mol Hum Reprod 15: 779-788.
96. Hobbs S, Jitrapakdee S, Wallace JC, (1998) Development of a bicistronic vector driven by the human polypeptide chain elongation factor 1alpha promoter for creation of stable mammalian cell lines that express very high levels of recombinant proteins. Biochem Biophys Res Commun 252: 368-372.
97. Vanderhyden BC, Caron PJ, Buccione R, Eppig JJ, (1990) Developmental pattern of the secretion of cumulus expansion-enabling factor by mouse oocytes and the role of oocytes in promoting granulosa cell differentiation. Dev Biol 140: 307-317.
98. Yi SE, Daluiski A, Pederson R, Rosen V, Lyons KM, (2000) The type I BMP receptor BMPRIB is required for chondrogenesis in the mouse limb. Development 127: 621-630.
99. Yoon BS, Ovchinnikov DA, Yoshii I, Mishina Y, Behringer RR, et al. (2005) Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo. Proc Natl Acad Sci USA 102: 5062-5067.
100. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
101. Lee K, Jeong J, Kwak I, Yu CT, Lanske B, et al. (2006) Indian hedgehog is a major mediator of progesterone signaling in the mouse uterus. Nat Genet 38: 1204-1209.
102. Park SO, Lee YJ, Seki T, Hong K-H, Fliess N, et al. (2008) ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. Blood 111: 633-642.